Compounds > sapindoside b
Page last updated: 2024-12-08

sapindoside b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sapindoside B: isolated from Locinera fulvotomentosa; structure given in first source; RN given refers to (3beta,4alpha)-isomer; RN for cpd without isomer designation not avail 12/89 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161686
SCHEMBL ID5971401
MeSH IDM0170826

Synonyms (8)

Synonym
sapindoside b
30994-75-3
(4as,6ar,6as,6br,8ar,9r,10s,12ar,14bs)-10-[(2s,3r,4s,5s)-3-[(2s,3r,4r,5s,6s)-3,5-dihydroxy-6-methyl-4-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,
olean-12-en-28-oic acid, 23-hydroxy-3-((o-beta-d-xylopyranosyl-(1-3)-o-6-deoxy-alpha-l-mannopyranosyl-(1-2)-alpha-l-arabinopyranosyl)oxy)-, (3beta,4alpha)-
SCHEMBL5971401
DTXSID40276505
HY-N11546
CS-0649357
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's3 (50.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.79 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
phenobarbital
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.. phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.		1.9910barbituratesanticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative
oleanolic acid
[no description available]		3.3160hydroxy monocarboxylic acid;
pentacyclic triterpenoid		plant metabolite
beta-hederin
beta-hederin: derived from beta-amyrin; other hederigenin based saponins are available		2.3820triterpenoid
beta-escin
[no description available]		3.3160
oleanane
oleanane: from the aerial roots of Ficus microcarpa; structure in first source		2.1310terpenoid fundamental parent;
triterpene
fulvotomentoside a
fulvotomentoside A: isolated from Lonicera fulvotomentosa; structure given in first source		1.9710
ConditionIndicatedRelationship StrengthStudiesTrials